November 29, 2016 / 5:20 PM / 9 months ago

BRIEF-Biophytis completes SARA-PK clinical study for Sarconeos in Sarcopenia

Nov 29 (Reuters) - Biophytis SA :

* Announces successful completion of SARA-PK clinical study for Sarconeos in Sarcopenia confirming safety profile

* Results of the study confirmed Sarconeos' appropriate safety profile, with no serious adverse events associated with the administration of sarconeos

* "We have strong confidence in Sarconeos' safety profile and will move forward with our Phase 2b SARA-INT study in 2017, as planned" - CEO

* Complete results of the SARA-PK study, in particular the pharmacokinetic profile of Sarconeos, will be available in the first quarter of 2017 Source text: bit.ly/2gCxi8B Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below